Via di Villa Maggiorani 20
00168 Roma
© 2019 angelabotta.it
Articoli su riviste internazionali e nazionali
1. De Carolis S, Grimolizzi F, Garofalo S, Fatigante G, Botta A, Ferrazzani S, Caruso A. L'autoimmunità nell'aborto abituale. Reumatismo 2003, 55(3), suppl 5.
2. De Carolis S, Botta A, Fatigante G, Garofalo S, Ferrazzani S, Gasbarrini A, Caruso A. Celiac Disease and inflammatory Bowel disease in pregnancy. Lupus 2004 13, 653-658 IF = 2.34
3. De Carolis S, Fatigante G, Grimolizzi F, Botta A, Garofalo S, Caruso A. Screening diagnostico nell’aborto ricorrente. Aggiornamento Medico 28, 1, 2004 ISSN: 0392-3002
4. De Carolis S, Grimolizzi F, Garofalo S, Botta A, Fatigante G, Martino C, Ferrazzani S, Caruso A. Minaccia di parto pre-termine: fattori di rischio e prevenzione. Aggiornamento Medico 28, 5, 2004 ISSN: 0392-3002
5. De Carolis S, Grimolizzi F, Botta A, Fatigante G, Martino C, Ferrazzani S, Caruso A. Gravidanza multipla. Aggiornamento Medico 28, 7, 2004 ISSN: 0392-3002
6. De Carolis S, Tomei C, Grimolizzi F, Martino C, Botta A, Paradisi G, Caruso A. Fisiopatologia, screening e diagnosi. Aggiornamento Medico (Speciale Diabete Gestazionale) 28,10,2004 ISSN: 0392-3002
7. De Carolis S, Tomei C, Grimolizzi F, Martino C, Botta A, Paradisi G, Caruso A. Complicanze materne e fetali. Aggiornamento Medico (Speciale Diabete Gestazionale), 28,10,2004 ISSN: 0392-3002
8. Paradisi G, Botta A, Ianniello F, Caruso A. Obesità e dismetabolismo in gravidanza. Aggiornamento Permanente in Ostetricia e Ginecologia (APOG). Dicembre 2004 volume 8 numero 3
9. De Carolis S, Botta A, Grimolizzi F, Garofalo S, Fatigante G, Martino C, Ferrazzani S, Caruso A. Lupus eritematoso sistemico e gravidanza. Aggiornamento Medico 29, 2, 2005 ISSN: 0392-3002
10. Guariglia L, Carducci B, Botta A, Ferrazzani S, Caruso A. Uterine prolapse in pregnancy. Gynecol Obstet Invest 2005 ;60: 192-19 IF=1.28
11. De Carolis S, Martino C, Fatigante G, Garofalo S, Botta A, Perrelli A, Santucci S. Patologie della tiroide in gravidanza. Aggiornamento Medico 25,7,2006 ISSN: 0392-3002
12. De Carolis S, Botta A, Garofalo S, Ferrazzani S, Martino C, Fatigante G, Caforio L, Caruso A. Uterine artery velocity waveforms as predictors of pregnancy outcome in patients with antiphospholipid sindrome: a review. Ann.N.Y.Acad. Sci. 2007 1108:530-539 IF=3.15
13. Boffa MC, Boinot C, De Carolis S, Rovere-Querini P, Aurousseau MH, Allegri F, Nicaise-Roland P, Barra A, Botta A, Ambrozic A, Avcin T, Tincani A. Laboratory criteria of the obstetrical antiphospholipid syndrome. Data from a multicentric prospective European women cohort. Thromb Haemost. 2009 Jul;102(1):25-8 IF=5.73
14. De Carolis S, Salvi S,Martino C, Lecca A, Degennaro V, Botta A, Scambia G. Malattie cardiache in gravidanza. Aggiornamento Medico 33,7,2009 ISSN: 0392-3002
15. De Carolis S, Botta A, Santucci S, Garofalo S, Martino C, Perrelli A, Salvi S, Ferrazzani S, Caforio L, Scambia G. Predictors of pregnancy outcome in antiphospholipid syndrome: a review. Clin Rev Allergy Immunol. 2010 Apr;38(2-3):116-24. Review IF=3.68
16. De Carolis S, Santucci S, Botta A, Garofalo S, Martino C, Perrelli A, Salvi S, Degennaro VA, de Belvis AG, Ferrazzani S, Scambia G. False-positive IgM for CMV in pregnant women with autoimmune disease: a novel prognostic factor for poor pregnancy outcome. Lupus. 2010; 19(7):844-9. IF = 2.34
17. De Carolis S, Salvi S, Botta A, Santucci S, Martino C, Garofalo S, Ferrazzani S. Which Intrauterine Treatment for Autoimmune Congenital Heart Block? The Open Autoimmunity Journal, 2010, 2, 1-10 ISSN: 1876-8946
18. Ruffatti A, Tonello M, Visentin M, Bontadi A, Hoxha A, De Carolis S, Botta A, Salvi S, Nuzzo M, Rovere-Querini P, Canti V, Mosca M, Mitic G, Bertero M, Pengo V, Boffa M, Tincani A. Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study. Rheumatology (Oxford). 2011 Jun 7. IF=4.06
19. De Carolis S, Moresi S, Botta A, Di Pasquo E, Degennaro Va, Martino C. Dopo la preeclampsia: quale futuro per la donna? Aggiornamento Medico 35, 3-4, 2011 ISSN: 0392-3002
20. De Carolis S, De Luca C, Botta A, Moresi S, Garofalo S, Martino C, Scambia G. Uso dei farmaci biologici in gravidanza nelle malattie infiammatorie croniche intestinali e nelle malattie autoimmuni. Aggiornamento Medico, 35, 2011 , ISSN: 0392-3002.
21. De Carolis S, Botta A, Santucci S, Salvi S, Moresi S, Di Pasquo E, Del Sordo G, Martino C. Complementemia and obstetric outcome in pregnancy with antiphospholipid syndrome. Lupus 2012, vol. 21, p. 776-778, ISSN: 0961-2033 IF=2.34
22. S. De Carolis, A. Botta, S. Salvi, G. Del Sordo, M.P. De Carolis Complementemia and obstetric outcome in Antiphospholipid syndrome pregnancies. Rheumatology (Oxford) 2012: 51(12)
23. De Carolis S, Santucci S, Botta A, Salvi S, Degennaro Va, Garufi C, Garofalo S, Ferrazzani S, Scambia G. The relationship between TORCH complex false positivity and obstetric outcome in patients with antiphospholipid syndrome. Lupus 2012, vol. 21, p. 773-775, ISSN: 0961-2033 IF= 2.34
24. Mekinian A, Lachassinne E, Nicaise-Roland P, Carbillon L, Motta M, Vicaut E, Boinot C, Avcin T Letoumelin P, De Carolis S, Rovere-Querini P, Lambert M, Derenne S, Pourrat O, Stirnemann J, Chollet-Martin S, Biasini-Rebaioli C, Rovelli R, Lojacono A, Ambrozic A, Botta A, Benbara A, Pierre F, Allegri F, Nuzzo M, Hatron P, Tincani A, Fain O, Aurousseau M, Boffa M. European registry of babies born to mothers with Antiphospholipid Syndrome. Ann Rheum Dis. 2013 Feb; 72(2): 217-22. IF=8.73
25. De Carolis S, Vitucci A, Garofalo S, Salvi S, Del Sordo G, Rella R, Botta A. Role of complement in pregnancy with antiphospholipid syndrome: mechanism of pathogenesis and clinical aspects. International Journal of Clinical Rheumatology 2013 ISSN: 1758-4272
26. De Carolis S, Salvi S, Del Sordo G, Botta A. Complementemia and obstetric outcome in antiphospholipid syndrome pregnancies. E-Letter to Editor published January 2013. Rheumatology (Oxford). IF=4.06
27. Ferrazzani S, Iadarola R, Perrelli A, Botta A, Moresi S, Salvi S, Santucci S, Degennaro VA, De Carolis S. Use of an intrauterine inflated catheter balloon in massive post-partum hemorrhage: a series of 52 cases. J Obstet Gynaecol Res. 2014 Jun;40(6):1603-10.
28. De Carolis S, Salvi S, Botta A, Garofalo S, Garufi C, Ferrazzani S, De Carolis MP. The impact of primary Sjogren's syndrome on pregnancy outcome: our series and review of the literature. Autoimmun Rev. 2014 Feb;13(2):103-7.
29. Mekinian A, Costedoat-Chalumeau N, Masseau A, Botta A. et al. Chronic histiocytic intervillositis: outcome, associated diseases and treatment in a multicenter prospective study. Autoimmunity. 2015 Feb;48(1):40-5.
30. Mekinian A, Costedoat-Chalumeau N, Masseau A, Tincani A, De Caroli S, Alijotas-Reig J, Ruffatti A, Ambrozic A, Botta A, et al. Obstetrical APS: is there a place for hydroxychloroquine to improve the pregnancy outcome? Autoimmun Rev. 2015 Jan;14(1):23-9
31. De Carolis MP, Salvi S, Botta A, Cocca C, Garufi C, Lanzone A, De Carolis S . Cerebral sinovenous thrombosis in neonatal antiphospholipid syndrome: a new entity?. Lupus. 2015 Mar;24 (3):231-4
32. De Carolis S, Botta A, Salvi S, di Pasquo E, Del Sordo G, Garufi C, Lanzone A, De Carolis MP. Is there any role for the hydroxychloroquine (HCQ) in refractory obstetrical antiphospholipid syndrome (APS) treatment? Autoimmun Rev. 2015 Sep;14 (9):760-2
33. Tabacco S, Salvi S, De Carolis S , Botta A, Ferrazzani S, Garufi C, Benedetti Panici P, Lanzone A, De Carolis MP. Predictors of Pregnancy Outcome in Antiphospholipid Syndrome: A Review. J Allergy Ther 2016
34. S De Carolis, S Tabacco, F Rizzo, G Perrone, C Garufi, A Botta et al. Association between false-positive TORCH and antiphospholipid antibodies in healthy pregnant women. Lupus 2018
35. De Carolis S, Tabacco S, Rizzo F, Giannini A, Botta A, Salvi S, Garufi C, Benedetti Panici P, Lanzone Antiphospholipid syndrome: An update on risk factors for pregnancy outcome. Autoimmun Rev. 2018
36. De Carolis S, Botta A, Del Sordo G, Guerrisi R, Salvi S, De Carolis MP, Iaconelli A, Giustacchini P, Raffaelli M, Lanzone A. Influence of Biliopancreatic Diversion on Pregnancy Outcomes in Comparison to Other Bariatric Surgery Procedures. Obes Surg. 2018
37. Neri C, Familiari A, Preziosi F, Vassallo C, Botta A, Lanzone A, Carducci B, Caruso A. Oral misoprostol versus intravaginal dinoprostone for labor induction: a comparison study. Minerva Ginecol. 2018
Abstract su riviste
1. Prevent of AV block by steroids during pregnancy: a case report. Lupus 2004, ISSN: 0961-2033
2. Systemic lupus erythematosus in pregnancy: maternal hypertension at conception as predictor factor for poor pregnancy outcome. Lupus 2004, ISSN: 0961-2033
3. False-positive IgM antibody tests for torch in pregnant women with SLE or APS Immunobiology 2005, ISSN: 0171-2985
4. Clinical follow up of babies born to mothers with APS. Clinical And Experimental Rheumatology 2007, vol. 25, p. 156, ISSN: 0392-856X
5. Immunological follow up of babies born to mothers with APS. Clinical And Experimental Rheumatology 2007, vol. 25, p. 156-157, ISSN: 0392-856X
6. False positive IgM antibody test for cytomegalovirus in pregnant women with autoimmune disease. Clinical And Experimental Rheumatology 2007, vol. 25, p. 155-156, ISSN: 0392-856X
7. Uterine artery velocity waveforms as predictors of pregnancy outcome in patients with antiphospholipid syndrome (APS). Thrombosis Research, vol. 119, p. S102, ISSN: 0049-3848
8. Neonatal Outcome in Hypertensive Disorders of Pregnancy: An Italian Sample. Hypertension in Pregnancy 2008, vol. 27, p. 678, ISSN: 1064-1955c
9. The role of heparin in the prevention of preeclampsia. Pregnancy Hypertension 2011, p. 245, ISSN:2210-7789.
Contributo in volumi
1. De Carolis S, Botta A. Malattie autoimmuni in gravidanza pag 481-489. Manuale di Ginecologia e Ostetricia. A. Caruso. CIC Edizioni Internazionali 2011
Atti congressuali
1. Systemic lupus erythematosus: clinical predictors of pregnancy outcome. Environmental Influences on reproduction and development. Chieti 11-12 Ottobre 2002
2. Inherited thrombophilia: Treatment during pregnancy. Environmental Influences on reproduction and development. Chieti 11-12 Ottobre 2002
3. La malattia tromboembolica in gravidanza: prevenzione. Agli atti congressuali del “Corso di aggiornamento su rischio tromboembolico in ostetricia e ginecologia” Ospedale S. Pertini Roma. 16 Settembre 2003
4. Trombofilia e Gravidanza. Agli atti congressuali del “Corso di aggiornamento su rischio tromboembolico in ostetricia e ginecologia” Ospedale S. Pertini Roma. 16 Settembre 2003
5. Systemic Lupus Erythematosus and pregnancy: clinical predictors. Agli atti dell’ 8° World Congress for infectious and immunological diseases in Obstetrics and Gynaecology”. Venezia, 8-11 Novembre 2003
6. L’autoimmunità nell’aborto ripetuto. Agli atti del “40° Congresso Nazionale SIR”. Udine, 21-22 Novembre 2003
7. Prevention of AV block by steroids during pregnancy: a case report. Lupus. 2004;13(9): 761. Agli atti del “Fourth International Conference on sex hormones, pregnancy and rheumatic diseases”. Stresa, 20-22 September 2004
8. Systemic Lupus Erythematosus in pregnancy: maternal hypertension at conception as predictor factor for poor pregnancy outcome. Lupus. 2004; 13(9): 751 Agli atti del “Fourth International Conference on sex hormones, pregnancy and rheumatic diseases” . Stresa, 20-22 September 2004
9. La placenta nell’aborto ricorrente. Atti della Società Italiana di Ginecologia e Ostetricia. Firenze 2005
10. “Register of babies born to mother with APS” agli atti del Congresso “V meeting of the European Forum on Anthiphospholipid Antibodies”. Barcellona, Spagna 2-3 dicembre 2005
11. “Profilassi eparinica nelle Trombofilie e Preeclampsia” agli atti del Congresso Nazionale Preeclampsia 2005. Ancona il 6-8 ottobre 2005
12. “Les e sindrome da Anticorpi Antifosfolipidi: sorveglianza materno-fetale e timing del parto” Agli atti del congresso “ Gravidanza ad alto rischio… management in assenza di EBM . Trieste 29-30 novembre 2005.
13. “Gestational Hypertension: progression to preeclampsia and predictive factors”, agli atti del 19° Congresso Europeo di Ostetricia e Ginecologia. Torino il 5-8 aprile 2006.
14. “One year experience of Day Hospital for diabetic pregnant women” agli atti del 19° Congresso Europeo di Ostetricia e Ginecologia. Torino il 5-8 aprile 2006.
15. “False-positive IgM antibody tests for TORCH in pregnant women with SLE or APS” agli atti del 19° Congresso Europeo di Ostetricia e Ginecologia. Torino il 5-8 aprile 2006
16. “The risk factors of pregnancy outcome in APS patients”, agli atti del Congresso “Syndrome Antiphospholipide: de la mere a l’enfant”. Groupe Hospitalier Pitiè-Salpetriere, Parigi, 9 giugno 2006.
17. “Gravidanza oltre il termine: induzione o attesa?”. Agli atti del Congresso SIGO Roma, Palazzo dei Congressi , Settembre 2006
18. “Esito della gravidanza in un campione di 280 adolescenti” Agli atti del Congresso SIGO Roma, Palazzo dei Congressi , Settembre 2006
19. “Uterine artery velocità waveforms as predictors of pregnancy outcome in patients with antiphospholipid sindrome”. Autoimmunity reviews. Agli atti del Congresso “5th International Congress on Autoimmunity”. Sorrento 29 novembre -3 dicembre 2006
20. “Uterine artery velocità waveforms as predictors of pregnancy outcome in patients with antiphospholipid sindrome”. Thrombosis and research. Agli atti del Congresso “ The 2nd International Symposium on Women’s Health Issues in Thrombosis and Haemostasis” .Vienna, Austria, 2-4 Febbraio 2007
21. “False positive IgM antibody test for Cytomegalovirus in pregnant women with autoimmune disease” Agli atti del Congresso “12th International Congress on Anthiphospholipid Antibodies”. Firenze 18-21 aprile 2007
22. “Clinical follow up of babies born to mothers with APS” Agli atti del Congresso “12th International Congress on Anthiphospholipid Antibodies” . Firenze 18-21 aprile 2007
23. “Immunological follow up of babies born to mothers with APS” Agli atti del Congresso “12th International Congress on Anthiphospholipid Antibodies”. Firenze 18-21 aprile 2007
24. 2° Congresso Nazionale di Preeclampsia Bologna 30 Novembre -2 dicembre 2007
25. Corso avanzato SIEOG di Neurosonologia fetale. Roma 10-11 Marzo 2008
26. Novel prognostic factors of pregnancy outcome in antiphospholipid syndrome (APS). In: Atti del "6th International Congress on Autoimmunity”. Oporto (Portogallo), 10-14 Settembre 2008
27. Neonatal outcome in hypertensive disorders of pregnancy: an italian sample. In: Atti del "XVI ISSHP World Congress". Washington 2008
28. Sindrome da anticorpi anti fosfolipidi: fattori prognostici in gravidanza. In: Atti del Workshop scientifico "Numana Madre e Feto". Numana, 14-16 maggio 2009
29. Pregnancy failure in spite of conventional treatment. In: Atti del "7th Meeting of the European Forum on Antiphospholid Antibodies". Marsiglia ( Francia) 2009
30. Preconceptional treatment with low dose aspirin versus low dose aspirin at the beginning of pregnancy. In: Atti del “7th Meeting of the European Forum on Antiphospholid Antibodies” Marsiglia ( Francia) 2009 .
31. The role of false positivity for TORCH infections and the role of previous EBV and TORCH infections in APS pregnancies. In: Atti del “7th Meeting of the European Forum on Antiphospholid Antibodies” Marsiglia ( Francia) 2009 .
32. Coagulopatia intravascolare disseminata. In: Atti del XVII Congresso Nazionale AGUI; XV Congresso Nazionale A.GI.CO; XI Congresso Nazionale AGEO; I Simposio CIGO; I Conferenza Nazionale Corsi di Laurea in Ostetricia" 2010
33. Proposal of a new prophilactic treatment of congenital heart block (CHB). In: Atti del "7th International Congress on Autoimmunity". Ljubljana, Slovenia, 5-9 maggio 2010
34. Hypocomplementemia as prognostic factor of pregnancy outcome in antiphospholipid syndrome (APS). In: Atti del "7th International Congress on Autoimmunity". Ljubljana, Slovenia, 5-9 maggio 2010
35. Etiologia della preeclampsia. In: Atti del simposio "Preeclampsia" Accademia Lancisiana. Roma 2010
36. Epidemiologia della preeclampsia. In: Atti del simposio "Preeclampsia" Accademia Lancisiana. Roma 2010
37. Trombofilia e preeclampsia. In: Atti del simposio "Preeclampsia" Accademia Lancisiana. Roma 2010
38. Tecniche conservative nell'emorragia del post-partum. In: "Emergenze ostetriche 2010" .
39. Parto operativo vaginale. In: "Emergenze ostetriche 2010" .
40. Placenta previa. In: Convegno " I rischi del nascere". 2010
41. Gravidanza e malattie autoimmuni organo-specifiche. Accademia Nazionale di Medicina: gravidanza nelle malattie autoimmuni Milano 10-11 Marzo 2010
42. Role of complement in pregnancy with APS. 9th Medinterna International Meeting “ Pearls in connective autoimmune diseases” Oporto (Portugal) 26-29 Gennaio 2011
43. False positivita' delle IgM anti-citomegalovirus (CMV) in gravidanze complicate da sindrome da anticorpi antifosfolipidi (APS). In: Atti del 18° Congresso Nazionale AGUI, 1° Congresso Nazionale AGIF, Congresso Annuale LAMM Ospedale e Territorio dedicati alla Donna 2011.
44. Continuous subcutaneous insulin infusion versus multiple daily injection in pregnant women with type 1 diabetes. In: Atti del congresso "Diabetes & Pregnancy" 2011.
45. Cancer in pregnancy: results of a series of 44 patients. In: XIV Congresso Nazionale SIMP (Società Italiana di Medicina Perinatale) I volti della maternità 2011.
46. Pre-pregnant body mass index (BMI) in women with gestational diabetes (GD) and pregnancy outcome. In: Atti del Congresso "World Diabetes Congress Dubai" 2011.
47. Pre-pregnant body mass index in women with gestational diabetes mellitus and pregnancy outcome. In: 14th World congress on controversies in obstetrics, gynecology & infertility (COGI). 2011
48. 6th International Symposium on Diabetes & Pregnancy DIP “Continuous Subcutaneous Insulin Infusion Versus multiple Daily Injection in pregnant women with Type 1 Diabetes" Salzburg, Austria 23-26 Marzo 2011
49. 6th International Symposium on Diabetes & Pregnancy DIP "Pre-pregnant Body Mass Index (BMI) in women with gestational diabetes (GD) and pregnancy outcome” Salzburg, Austria 23-26 Marzo 2011
50. Complementemia and obstetric outcome in pregnancy with APS. 8th Meeting of the European Forum on Antiphospholipid Antibodies. Padova, Italia. 29 Settembre - 1 Ottobre 2011
51. The relationship between torch complex false positivity and obstetric outcome in patients with APS. 8th Meeting of the European Forum on Antiphospholipid Antibodies. Padova, Italia. 29 Settembre - 1 Ottobre 2011
52. "Pre-pregnant Body Mass Index (BMI) in women with gestational diabetes (GD) and pregnancy outcome”. 3° congresso nazionale SIDIP . Roma CNR 26-28 ottobre 2011. (1° PREMIO POSTER SIDIP 2011).
53. The impact of Sjogren's syndrome (SS) on perinatal outcome: a prospective study. In: Atti de: 8th International Congress of Autoimmunity, Granada (Spagna) Maggio 2012
54. The role of CMV-IgM false positivity in pregnancies complicated by antiphospholipid syndrome (APS): a new prognostic factor. In: Atti de: 8th International Congress of Autoimmunity Granada (Spagna) Maggio 2012
55. Hypocomplementemia: a prognostic factor of poor pregnancy out come in antiphospholipid syndrome (APS). In: Atti de: 8th International Congress of Autoimmunity Granada (Spagna) Maggio 2012
56. Development of a new fetal growth curve for the Italian population. In: XX FIGO World Congress of Gynecology and Obstetrics. Roma Ottobre 2012
57. Role of complement in the obstetric complications of Antiphospholipid Syndrome. 9th Meeting of the European Forum on Antiphospholipid Antibodies. Cracovia ( Polonia) Maggio 2013
58. Congresso Associazione Italiana Preeclampsia AIPE Roma 28-29 Settembre 2017
59. Profilassi e trattamento del Parto pretermine Congresso SIGO Ottobre 2018
59. Influence of Biliopancreatic Diversion on Pregnancy Outcomes in Comparison to Other Bariatric Surgery Procedures DIP Firenze 2019